Home example 2 - Pharmamarketeer

wet- en regelgeving

Keytruda scores EU approval in combination with Inlyta for first-line advanced renal cell carcinoma

The European Commission has awarded yet another authorisation in the region to MSD’s Keytruda, this time in combination with the tyrosine kinase inhibitor Inlyta (axitinib) in the first-line treatment of advanced renal...

InPharm.com

27 x gelezen

wet- en regelgeving

FDA Approves Biogen’s TOFIDENCE

FDA Approves Biogen’s TOFIDENCE Biogen has announced that the US Food and Drug Administration (FDA) has approved Tofidence (tocilizumab-bavi) as an intravenous formulation, a biosimilar monoclonal antibody...

InPharm.com

27 x gelezen

onderzoek

Study provides greater detail about the characteristics of COVID-19 patients

COVID-19 patients Patients hospitalized with COVID-19 were more likely male, younger, and, in both the US and Spain, had fewer comorbidities and lower medication use than hospitalized influenza patients according to a...

News-Medical.Net

27 x gelezen

overig

Boehringer sues US government over Medicare drug price negotiation programme

Boehringer sues US government over Medicare drug price negotiation programme Boehringer Ingelheim has become the latest drugmaker to sue the US government over the Medicare drug price negotiation element of President...

PMLiVE

27 x gelezen

marketing

The Marketing Mandate for 2024: Build Stronger Bonds With Your Audience

The Marketing Mandate for 2024: Build Stronger Bonds With Your Audience I’ve been thinking about something that will impact marketing in 2024: Relationships. And I mean specifically the relationships between your brand...

Content Marketing Institute

27 x gelezen

marketing

De AI Mindset Shift: Hoe ik AI Elke Dag Gebruik

De AI Mindset Shift: Hoe ik AI Elke Dag Gebruik Ik ben in slechts een paar maanden van een incidentele AI-gebruiker naar een ervaren gebruiker gegaan. Hoe? Mijn mindset over hoe ik AI benaderde, is geëvolueerd. Nu...

The Buffer Blog

27 x gelezen

overig

Nederland betaalt lang hoge prijzen voor dure geneesmiddelen

Nederland betaalt lang hoge prijzen voor dure geneesmiddelen Uit een analyse van de Nederlandse Zorgautoriteit (NZa) blijkt dat het lang duurt voordat er concurrentie ontstaat voor nieuwe medicijnen. Bij het afgeven van...

Nederlandse Zorgautoriteit

27 x gelezen

technologie

Use of digital technologies to be tapped for future growth of pharma industry: Says report

Use of digital technologies to be tapped for future growth of pharma industry The use of digital technologies including telemedicine and e-pharmacy services may be harnessed to enhance the distribution network and...

Pharma Biz

27 x gelezen

marketing

Is machine learning de redding voor de cookieloze marketeer?

Is machine learning de redding voor de cookieloze marketeer? Na jaren van fijn data verzamelen naderen we nu een wereld zonder third-party cookies. Hoe nu verder? Machine learning kan uitkomst bieden. Het kan marketeers...

Redactie

27 x gelezen

wet- en regelgeving

Five things for pharma marketers to know for Thursday morning

Five things for pharma marketers to know The Food and Drug Administration approved Novartis’ treatment for adults with a rare, serious blood disorder known as paroxysmal nocturnal hemoglobinuria (PNH). Pfizer decided to...

MMM - Medical Marketing and Media

27 x gelezen

Latest articles

Keytruda scores EU approval in combination with Inlyta for first-line advanced renal cell carcinoma

FDA Approves Biogen’s TOFIDENCE

Study provides greater detail about the characteristics of COVID-19 patients

Boehringer sues US government over Medicare drug price negotiation programme

The Marketing Mandate for 2024: Build Stronger Bonds With Your Audience

De AI Mindset Shift: Hoe ik AI Elke Dag Gebruik

Nederland betaalt lang hoge prijzen voor dure geneesmiddelen

Use of digital technologies to be tapped for future growth of pharma industry: Says report

Is machine learning de redding voor de cookieloze marketeer?

Five things for pharma marketers to know for Thursday morning

Wekelijkse highlights per e-mail

Algemene informatie